IP Library Granted Patent US 7,473,532
Granted Patent B2
US 7,473,532 · App. 10/796,288 · Granted Jan 6, 2009

Liquid tissue preparation from histopathologically processed biological samples, tissues and cells

Assignee: Expression Pathology, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,473,532
App. No.
10/796,288
Filed
Mar 10, 2004
Granted
Jan 6, 2009
Kind
B2
Art Unit
1657
USPC
435/7.2
Abstract

The current invention provides a method for directly converting histopathologically processed biological samples, tissues, and cells into a multi-use biomolecule lysate. This method allows for simultaneous extraction, isolation, solublization, and storage of all biomolecules contained within the histopathologically processed biological sample, thereby forming a representative library of said sample. This multi-use biomolecule lysate is dilutable, soluble, capable of being fractionated, and used in any number of subsequent experiments.

Claims (20)

1. A method of preparing a biomolecule lysate, comprising the steps of:

(a) heating a composition comprising a formalin fixed biological sample and a reaction buffer at a temperature from 80° C. to 100° C. for a period of time from 10 minutes to 4 hours to reverse or release protein cross-linking in said biological sample, and

(b) treating the resulting composition with an effective amount of a proteolytic enzyme selected from the group consisting of trypsin, chymotrypsin, and endoproteinase Lys-C for a period of time from 30 minutes to 24 hours at a temperature from 37° C. to 65° C. to disrupt the tissue and cellular structure of said biological sample and to liquefy said sample, thereby producing a liquid, soluble, dilutable biomolecule lysate that is suitable for protein analysis and wherein the protein content of said lysate is representative of the total protein content of said biological sample.

2. The method according to claim 1 , wherein said biological sample comprises a homogeneous population of tissues or cells.

3. The method according to claim 1 , further comprising, prior to step (a), the step of removing any paraffin present in said biological sample by one or more methods selected from the group consisting of: adding an organic solvent; heating; heating and adding a buffer comprising Tris; and heating and adding an organic solvent.

4. The method according to claim 1 , further comprising, prior to step (b), the step of mechanically disrupting said biological sample by at least one technique selected from the group consisting of: manual homogenization; vortexing; and physical mixing.

5. The method according to claim 1 , wherein said reaction buffer comprises a detergent.

6. The method according to claim 1 , wherein step (b) is carried out in the presence of a detergent.

7. The method according to claim 1 , wherein said reaction buffer comprises Tris and has a pH in the range of 1.0 to 9.0.

8. The method of claim 1 , further comprising assaying said biomolecule lysate using mass spectrometry.

9. The method according to claim 1 , wherein said reaction buffer comprises Tris and has a pH in the range of 6.0 to 9.0.

10. A method of preparing a biomolecule lysate, comprising the steps of:

(a) heating a composition comprising a formalin fixed biological sample and a reaction buffer at a temperature from 80° C. to 100° C. for a period of time from 10 minutes to 4 hours to reverse or release protein cross-linking in said biological sample,

(b) treating the resulting composition with an effective amount of a proteolytic enzyme selected from the group consisting of trypsin, chymotrypsin, and endoproteinase Lys-C for a period of time from 30 minutes to 24 hours at a temperature between 37° C. to 65° C. to disrupt the tissue and cellular structure of said biological sample and to liquefy said sample, thereby producing a liquid, soluble, dilutable biomolecule lysate that is suitable for protein analysis and wherein the protein content of said lysate is representative of the total protein content of said biological sample, and

fractionating said biomolecule lysate into distinct and separate biomolecule fractions.

11. The method according to claim 10 , wherein each biomolecule fraction contains distinct and separate biomolecules suitable for use in biochemical assays.

12. The method according to claim 1 , wherein said biological sample is selected from a group consisting of formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks, and tissue culture cells that have been formalin fixed and or paraffin embedded.

13. The method of claim 10 , wherein said fractionating is carried out using a method selected from the group consisting of step spin column fractionation, immunoprecipitation, gradient centrifugation, HPLC and drip column fractionation.

14. The method according to claim 5 , wherein said detergent is selected from the group consisting of NONIDET P40, SDS, TWEEN 20, TRITON X, and sodium deoxycholate.

15. The method according to claim 6 , wherein said detergent is selected from the group consisting of NONIDET P40, SDS, TWEEN 20, TRITON X, and sodium deoxycholate.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded May 16, 2016
From: CALIFORNIA CAPITAL EQUITY LLC; NANT CAPITAL LLC
To: EXPRESSION PATHOLOGY INCORPORATED
Reel/Frame 038609/0312 →
SECURITY AGREEMENT Recorded Dec 10, 2012
From: EXPRESSION PATHOLOGY INCORPORATED
To: CALIFORNIA CAPITAL EQUITY LLC; NANT CAPITAL LLC
Reel/Frame 029441/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2004
From: DARFLER, MARLENE M.; KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 015353/0307 →
Continuity (2)
Provisional Application 6045295600 · Mar 10, 2003
Related Publication 20050014203A1 · Jan 20, 2005